Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T22:33:29.816Z.
Calculation as of: 2026-10-06T22:33:29.816Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8f998ac52bf92492c18c8c1a056427339c5b213780e3da80cf9ae2163b61907c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2021-08-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Treace Medical Concepts, Inc.
Market Cap
$259.49M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.56M
EV/EBITDA Ratio
N/A
TTM Avg
2.41x
3Y Avg
3817.71x
5Y Avg
2177.76x
Market Cap
$259.14M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$259.12M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.63M
EV/EBITDA Ratio
N/A
TTM Avg
128764.90x
3Y Avg
128764.90x
5Y Avg
128764.90x
Market Cap
$261.43M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.92M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Treace Medical Concepts, Inc. (TMCI) | $259.49M | N/A | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $259.56M | N/A | 2.41x | 3817.71x | 2177.76x |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.14M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $259.12M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | N/A | 128764.90x | 128764.90x | 128764.90x |
| X4 Pharmaceuticals, Inc. (XFOR)vs › | $261.27M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $256.47M | N/A | 15.20x | 12.43x | 15.17x |
| TriSalus Life Sciences, Inc. (TLSI)vs › | $262.92M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | 473.06x | 197.45x | 157.93x | 101.85x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2021-08-05 | 854.94x |
| 2021-08-04 | 854.64x |
| 2021-08-03 | 889.29x |
| 2021-08-02 | 908.57x |
| 2021-07-30 | 919.41x |
| 2021-07-29 | 885.07x |
| 2021-07-28 | 874.53x |
| 2021-07-27 | 839.58x |
| 2021-07-26 | 822.10x |
| 2021-07-23 | 823.31x |
| 2021-07-22 | 831.44x |
| 2021-07-21 | 858.56x |
| 2021-07-20 | 843.49x |
| 2021-07-19 | 836.26x |
| 2021-07-16 | 841.99x |
| 2021-07-15 | 829.33x |
| 2021-07-14 | 847.11x |
| 2021-07-13 | 876.33x |
| 2021-07-12 | 882.66x |
| 2021-07-09 | 864.28x |
| 2021-07-08 | 893.81x |
| 2021-07-07 | 919.11x |
| 2021-07-06 | 882.06x |
| 2021-07-02 | 911.58x |
| 2021-07-01 | 926.64x |
| 2021-06-30 | 949.54x |
| 2021-06-29 | 926.04x |
| 2021-06-28 | 964.91x |
| 2021-06-25 | 941.71x |
| 2021-06-24 | 956.77x |
| 2021-06-23 | 993.53x |
| 2021-06-22 | 1025.76x |
| 2021-06-21 | 1016.42x |
| 2021-06-18 | 1017.33x |
| 2021-06-17 | 1055.89x |
| 2021-06-16 | 1076.07x |
| 2021-06-15 | 1058.90x |
| 2021-06-14 | 1043.84x |
| 2021-06-11 | 1095.66x |
| 2021-06-10 | 1080.59x |
| 2021-06-09 | 1080.59x |
| 2021-06-08 | 1090.84x |
| 2021-06-07 | 1058.00x |
| 2021-06-04 | 1092.95x |
| 2021-06-03 | 1092.04x |
| 2021-06-02 | 1081.80x |
| 2021-06-01 | 1030.88x |
| 2021-05-28 | 985.39x |
| 2021-05-27 | 981.78x |
| 2021-05-26 | 898.63x |
| 2021-05-25 | 692.69x |
| 2021-05-24 | 696.35x |
| 2021-05-21 | 709.30x |
| 2021-05-20 | 726.17x |
| 2021-05-19 | 735.45x |
| 2021-05-18 | 748.40x |
| 2021-05-17 | 723.72x |
| 2021-05-14 | 725.68x |
| 2021-05-13 | 667.52x |
| 2021-05-12 | 764.29x |
| 2021-05-11 | 812.43x |
| 2021-05-10 | 811.94x |
| 2021-05-07 | 802.17x |
| 2021-05-06 | 741.81x |
| 2021-05-05 | 748.40x |
| 2021-05-04 | 702.22x |
| 2021-05-03 | 743.27x |
| 2021-04-30 | 772.60x |
| 2021-04-29 | 722.74x |
| 2021-04-28 | 714.92x |
| 2021-04-27 | 770.40x |
| 2021-04-26 | 713.46x |
| 2021-04-23 | 630.13x |
